Hôpital d'Instruction des Armées Saint-Anne, Toulon), A Genin (Centre Hospitalier du Pays d' Aix, A Mottard, 2015. ,
, Geneva: World Health Organization, 2018.
Artemisinin-based combination treatment of falciparum malaria, Am J Trop Med Hyg, vol.77, pp.181-92, 2007. ,
Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-67, 2009. ,
Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, pp.411-434, 2015. ,
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa, Malar J, vol.15, p.10, 2016. ,
Partner-drug resistance and population substructuring of artemisininresistant Plasmodium falciparum in Cambodia, Genome Biol Evol, vol.9, pp.1673-86, 2017. ,
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00921203
A worldwide map of Plasmodium falciparum K13-propeller polymorphisms, N Engl J Med, vol.374, pp.2453-64, 2016. ,
Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia, Malar J, vol.16, p.195, 2017. ,
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire, Antimicrob Agents Chemother, vol.59, pp.437-480, 2015. ,
West Africa international centers of excellence for malaria research: drug resistance patterns to artemether-lumefantrine in Senegal, Mali, and the Gambia, Am J Trop Med Hyg, vol.95, pp.1054-60, 2016. ,
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, Malar J, vol.16, p.62, 2015. ,
Pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemetherlumefantrine in the United Kingdom, Antimicrob Agents Chemother, vol.61, pp.2382-2398, 2017. ,
Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal, Int J Antimicrob Agents, vol.49, pp.754-760, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01573744
Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility, Proc Nath Acad Sci USA, vol.115, pp.12799-804, 2018. ,
Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT, J Infect Dis, vol.210, pp.2001-2009, 2014. ,
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, Lancet Infect Dis, vol.15, pp.683-91, 2015. ,
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, Lancet Infect Dis, vol.16, pp.357-65, 2016. ,
Treatment failure of dihydroartemisinin/piperaquine for Plasmodium falciparum malaria, Emerg Infect Dis, vol.23, pp.715-722, 2017. ,
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam, Malar J, vol.16, p.27, 2017. ,
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, pp.174-83, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01400955
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study, Lancet Infect Dis, vol.17, pp.164-73, 2017. ,
Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda, J Infect Dis, vol.216, pp.1008-1025, 2017. ,
Changing antimalarial drug sensitivities in Uganda. Antimicrob Agents Chemother, vol.61, pp.1516-1533, 2017. ,
Efficacy and safety of artemisinin-based combination therapy and molecular markers for artemisinin and piperaquine resistance in Mailand Tanzania, Malar J, vol.17, p.369, 2018. ,
Absence of high level of duplication of the plasmepsin 2 gene in Africa, Antimicrob Agents Chemother, vol.62, pp.374-392, 2018. ,
Baseline ex vivo and molecular responses of Plasmodium falciparum isolates to piperaquine before implementation of dihydroartemisinin-piperaquine in Senegal, Antimicrob Agents Chemother, vol.63, pp.2445-2463, 2019. ,
Emerging Southeast Asian Pfcrt mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine, Nat Commun, vol.9, p.3314, 2018. ,
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell, vol.6, pp.861-71, 2000. ,
ABC transporters in Plasmodium and their involvement in resistance to antimalarial drugs, pp.113-141, 2009. ,
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies, Nat Commun, vol.7, p.11553, 2016. ,
Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum, Mol Microbiol, vol.57, pp.13-926, 2005. ,
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, vol.364, pp.438-485, 2004. ,
Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity, Antimicrob Agents Chemother, vol.60, pp.5649-54, 2016. ,
The 'permeome' of malaria parasite: an overview of the membrane transport protein of Plasmodium falciparum, Genome Biol, vol.6, p.26, 2015. ,
Structural biology of the major facilitator superfamily transporters, Annu Rev Biophys, vol.44, pp.257-83, 2015. ,
UDPgalactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes, Nat Microbiol, vol.19, p.16166, 2016. ,
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission, Antimicrob Agents Chemother, vol.58, pp.5060-5067, 2014. ,
Antimalarial activity of KAF156 in falciparum and vivax malaria, N Engl J Med, vol.375, pp.1152-60, 2016. ,
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery, Science, vol.334, pp.1372-1379, 2011. ,
Mutations in the Plasmodium falciparum cyclic amine resistance locus (PfCARL) confer multidrug resistance, Mbio, vol.7, pp.696-712, 2016. ,
Plasmodium falciparum cyclic amine resistance locus (PfCARL), a resistance mechanism for two distinct compounds classes, ASC Infect Dis, vol.2, pp.816-842, 2016. ,
Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum, Science, vol.323, pp.1693-1700, 2009. ,
Prevalence of anti-malarial resistance gens in Dakar, Senegal from 2013 to, Malar J, vol.15, p.347, 2014. ,
Plasmodium falciparum in vitro resistance to monodesethylamodiaquine, Emerg Infect Dis, vol.22, pp.841-846, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01521245
Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Malar J, vol.16, p.118, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01521245
Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests, Malar J, vol.12, p.34, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00787797
Use of the atmospheric generators for capnophilic bacteria Genbag-CO 2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs, Malar J, vol.10, issue.8, 2011. ,
Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveler returning from South-East Asia, Malar J, vol.10, p.268, 2011. ,
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine, Malar J, vol.14, p.49, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01221323
Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season, Malar J, vol.14, p.60, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01220028
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-962, 2006. ,
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-51, 2006. ,
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations, BMC Med, vol.13, p.305, 2015. ,
Field application of in vitro assays for the sensitivity of human malaria parasites to antimalarial drugs. Geneva: World health Organization, pp.69-71, 2007. ,
convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year ,
, Ready to submit your research ? Choose BMC and benefit from
Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates, Am J Trop Med Hyg, vol.62, pp.82-87, 2000. ,
In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron, Antimicrob Agents Chemother, vol.45, pp.1746-50, 2001. ,
Influence of oxygen on asexual blood cycle and susceptibilily of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay, Malar J, vol.6, p.44, 2007. ,
Reliability of antimalarial sensitivity tests depends on drug mechanism of action, J Clin Microbiol, vol.48, pp.1651-60, 2010. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations